ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256927 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256927; 2) Community: the network communities that were significantly associated with the response to NSC 256927; 3) Molecule: the relationships between components within communities and NSC 256927; 4) MDR: the compounds that were significantly associated with the NSC 256927.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.0462077035966088 0.4275941
NSC 109836 Null 0.0462077035966088 0.39741146
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0462077035966088 0.401086
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0462077035966088 0.51014691
NSC 134725 K-33 0.0462077035966088 0.55815981
NSC 176324 5-Isoxazoleacetic acid, .alpha.-amino-3-chloro-4,5-dihydro-4-hydroxy-, (4R-(4.alpha.,5.beta.(S*)))- 0.0462077035966088 0.35565576
NSC 115980 Null 0.0467178916101838 0.3445057
NSC 153325 Null 0.0467178916101838 0.2299466
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0467178916101838 0.4918983
NSC 175630 Toyocamycin, 6-amino- 0.0467178916101838 0.39891333
Total:80  Current:76    [First] [Prev] [Next] [Last]